Observational studyMedicine2017

99mTc-pertechnetate-avid metastases from differentiated thyroid cancer are prone to benefit from 131I therapy: A prospective observational study.

Min Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.